Lucid Diagnostics
LUCD
#8956
Rank
A$0.20 B
Marketcap
A$1.55
Share price
-2.83%
Change (1 day)
18.17%
Change (1 year)

Lucid Diagnostics (LUCD) - Cash on Hand

Cash on Hand as of September 2025 : A$71.27 Million

According to Lucid Diagnostics's latest financial reports the company has A$71.27 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lucid Diagnostics - Cash on Hand chart (from 2020 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$35.94 M29.6%
2023-12-31A$27.73 M-16.02%
2022-12-31A$33.02 M-55.38%
2021-12-31A$74.01 M51169.07%
2020-12-31A$0.14 M-35.38%
2019-12-31A$0.22 M